Human vaccines & immunotherapeutics

Keyphrases

Publications

volume 19, number 3, 2023

Sylvie Pichon, Francoise Guinet-Morlot, Jamshid Saleh, Brandon Essink, Andrea-Clemencia Pineda-Peña, Annick Moureau, Celine Petit, Ada-Maria Minutello
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults. Human vaccines & immunotherapeutics 19 (3) (2023)
Jennifer Connors, Gina M Cusimano, Nathan J Mege, Kyra Woloszczuk, Emily Konopka, Matthew R Bell, David Joyner, Jennifer Marcy, Virginie Tardif, Michele A Kutzler, Roshell Muir, Elias K Haddad
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity. Human vaccines & immunotherapeutics 19 (3) (2023)
Xuan Yang, Mingcong Chen, Lin Cao, Ming-Yi Zhao
Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023. Human vaccines & immunotherapeutics 19 (3) (2023)
Somsri Wiwanitkit, Rujittika Mungmunpuntipantip
Intraneural ganglion cyst of the peroneal nerve and coronavirus disease-19 vaccination: Relationship and possible mechanism. Human vaccines & immunotherapeutics 19 (3) (2023)
Lijia Ou, Chang Su, Liang Liang, Qintong Duan, Yufeng Li, Hui Zang, Yizi He, Ruolan Zeng, Yajun Li, Hui Zhou, Ling Xiao
Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis. Human vaccines & immunotherapeutics 19 (3) (2023)
Aye M Moa, Mohana Priya Kunasekaran, Zubair Akhtar, Valentina Costantino, Chandini Raina Macintyre
Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities. Human vaccines & immunotherapeutics 19 (3) (2023)
Robert K Bright
Preclinical support for tumor protein D52 as a cancer vaccine antigen. Human vaccines & immunotherapeutics 19 (3) (2023)
Sandro Giuffrida, Giovanna Seta, Antonio Gurnari, Fabiana Fiasca, Federico Marchetti
Insights and expectations of healthcare professionals on the implementation of the updated pediatric regional immunization Calendar in Calabria, Italy. Human vaccines & immunotherapeutics 19 (3) (2023)
Francesco Paolo Bianchi, Pasquale Stefanizzi, Antonio Di Lorenzo, Chiara De Waure, Stefania Boccia, Antonio Daleno, Giovanni Migliore, Stefano Termite
Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis. Human vaccines & immunotherapeutics 19 (3) (2023)
Danna Valinsky, Anthony D Heymann, Dov Albukrek, Judith Tsamir, Galia Zacay
The critical factors for COVID-19 vaccination uptake are perceived ‎vaccine effectiveness and the desire to protect others. Human vaccines & immunotherapeutics 19 (3) (2023)
Monica Anne McArthur, Siham Bchir, Estelle Dubois, Lucia Gan, Eric Gerchman, Sandeep Gupta, Olga Liabis, Lucia Perez, Fabienne Roche, Gustavo Vasquez, Betzana Zambrano, Sanjay Gurunathan, Mandeep Singh Dhingra
"Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials". Human vaccines & immunotherapeutics 19 (3) (2023)
Rebecca B Perkins, Sharon Humiston, Kristin Oliver
Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview. Human vaccines & immunotherapeutics 19 (3) (2023)
Samiyah Alshehri, Malik Sallam
Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities. Human vaccines & immunotherapeutics 19 (3) (2023)
Trevor Christensen, Sherri Zorn, Kathy Bay, Katherine Treend, Chrystal Averette, Nicole Rhodes
Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state. Human vaccines & immunotherapeutics 19 (3) (2023)
Mengjie Guo, Jian'an Li, Yan Wang, Guimei Chen, Ren Chen, Li Wang
The association between influenza vaccination and the perception of COVID-19 as well as COVID-19 vaccination behavior among community residents in Anhui province, China. Human vaccines & immunotherapeutics 19 (3) (2023)
Sanda Ravlić, Tihana Kurtović, Lidija Cvetko Krajinović, Ana Hećimović, Marija Miloš, Sanja Mateljak Lukačević, Alemka Markotić, Beata Halassy
What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees? Human vaccines & immunotherapeutics 19 (3) (2023)
Yuanfang Tan, Huiyuan Chen, Xi Gou, Qiuying Fan, Juanjuan Chen
Tumor vaccines: Toward multidimensional anti-tumor therapies. Human vaccines & immunotherapeutics 19 (3) (2023)
Isabelle Williame, Marina George, Hiral Anil Shah, Natalia Homer, David Alderson, Nicolas Jamet
Healthcare resource use and costs of varicella and its complications: A systematic literature review. Human vaccines & immunotherapeutics 19 (3) (2023)
Guglielmo Arzilli, Lorenzo Stacchini, Virginia Casigliani, Sara Mazzilli, Francesco Aquino, Aurea Oradini-Alacreu, Beatrice Bruni, Filippo Quattrone, Francesca Papini, Daniele Sironi, Andrea Davide Porretta, Gaetano Pierpaolo Privitera, Caterina Rizzo, Lara Tavoschi, Pier Luigi Lopalco
Assessing vaccine hesitancy and health literacy using a new Italian vaccine confidence index and a modified Italian medical term recognition test: A cross-sectional survey on Italian parents. Human vaccines & immunotherapeutics 19 (3) (2023)
Rujittika PhD Mungmunpuntipantip, Rujittika Mungmunpuntipantip
COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: Correspondence. Human vaccines & immunotherapeutics 19 (3) (2023)
Amal Khan, Sylvia Abonyi, Cordell Neudorf, Sandro Galea, Shahid Ahmed
Barriers to and facilitators of human papillomavirus vaccination in an ethnically diverse group of migrant parents: A qualitative mixed methods study. Human vaccines & immunotherapeutics 19 (3) (2023)
Veronika Simeonova Dimitrova, Savina Stoitsova, Vanya Rangelov, Ralitsa Raycheva, Maria Martinova, Gergana Nenova, Milena Iakimova, Irina Georgieva, Ivo Georgiev, Stefka Krumova, Antoaneta Minkova, Nadezhda Vladimirova, Lubomira Nikolaeva-Glomb
High vaccine confidence and strong approval of the mandatory immunization schedule among Bulgarian general practitioners in 2022. Human vaccines & immunotherapeutics 19 (3) (2023)
Hua Ye, Wenwen Yu, Yunlei Li, Xiaoqiong Bao, Yangyang Ni, Xiangxiang Chen, Yangjie Sun, Ali Chen, Weilong Zhou, Jifa Li
AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3. Human vaccines & immunotherapeutics 19 (3) (2023)
Wan Muhammad Azfar Wan Shuaib, Izzatul Aliaa Badaruddin, Munirah Mansor, Sharifah Azura Salleh, Mohd Rohaizat Hassan, Steward Lindong, Shahril Nizam Samad, Hanita Othman
SARS-CoV-2 S-RBD IgG & Neutralizing antibodies among different categories of health care workers post third dose BNT162b2 mRNA COVID-19 vaccine. Human vaccines & immunotherapeutics 19 (3) (2023)
Pasquale Stefanizzi, Francesco Paolo Bianchi, Lorenza Moscara, Andrea Martinelli, Antonio Di Lorenzo, Loreto Gesualdo, Simona Simone, Maria Rendina, Stefano Termite
Determinants of compliance to influenza and COVID-19 vaccination in a cohort of solid organ transplant patients in Puglia, Southern Italy (2017-2022). Human vaccines & immunotherapeutics 19 (3) (2023)
Zainab Hassan Yussuph, Fadhlun M Alwy Al-Beity, Furaha August, Amani Anaeli
COVID-19 vaccine hesitancy among pregnant women attending public antenatal clinics in Dar es Salaam, Tanzania. Human vaccines & immunotherapeutics 19 (3) (2023)
Nack Hwan Kim
Intraneural ganglion cyst of the peroneal nerve occurring after coronavirus disease-19 vaccination: A case report. Human vaccines & immunotherapeutics 19 (3) (2023)
Albert Jang, Jake N Lichterman, Jeffrey Y Zhong, Jonathan E Shoag, Jorge A Garcia, Tian Zhang, Pedro C Barata
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. Human vaccines & immunotherapeutics 19 (3) (2023)
Nan Wang, Zehua Mi, Shuang Chen, Xiaoyang Fang, Zhipeng Xi, Wenqiang Xu, Lin Xie
Analysis of global research hotspots and trends in immune cells in intervertebral disc degeneration: A bibliometric study. Human vaccines & immunotherapeutics 19 (3) (2023)
Sarah R MacEwan, Eben Kenah, Graham N Dixon, Jack Stevens, Leanna Perez Eiterman, Jonathan R Powell, Christopher B Gage, Laura J Rush, Ashish R Panchal, Ann Scheck McAlearney
Identifying beliefs driving COVID-19 vaccination: Lessons for effective messaging. Human vaccines & immunotherapeutics 19 (3) (2023)
Adriana Sánchez-García, Reyes Tamez-Guerra, Gerardo González-Saldivar, Rene Rodriguez-Gutierrez, Luz Adriana Ramírez-García, Francisco J Barrera, José Gerardo González-González
The safety of BCG revaccination in the context of COVID-19. Human vaccines & immunotherapeutics 19 (3) (2023)
Rose P Webster, Jordan A Marckel, Andrew B Norman
Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity. Human vaccines & immunotherapeutics 19 (3) (2023)
Cristiana Ferrari, Giuseppina Somma, Luca Coppeta
Immunity to measles in COVID-19 era. Human vaccines & immunotherapeutics 19 (3) (2023)
Tao Cheng, Yaping You, Bochao Jia, Huan Wang, Meng Lv, Xueping Zhu, Yuanhui Hu
Knowledge mapping of B cell and atherosclerosis over the past 20 years: A bibliometric analysis. Human vaccines & immunotherapeutics 19 (3) (2023)
Jiqing Ma, Kaiwen Zhao, Yalin Zhu, Wen Xu, Jie Huang, Xiaolong Wei, Zhiqing Zhao
Bibliometric analysis of monoclonal antibodies for atherosclerosis. Human vaccines & immunotherapeutics 19 (3) (2023)
Wenwen Gu, Yan Liu, Qinghua Chen, Jun Wang, Xinren Che, Jian Du, Xiaoping Zhang, Yuyang Xu, Xuechao Zhang, Wei Jiang, Jing Wang, Qixin Xie, Zhaojun Lu, Yingying Yang, Lintao Gu, Junfang Chen
Acceptance of influenza vaccination and associated factors among teachers in China: A cross-sectional study based on health belief model. Human vaccines & immunotherapeutics 19 (3) (2023)
Shiwei Ma, Xin Wu, Zhongguang Wu, Qiangqiang Zhao
Treatment-prognostication-adjustment a new therapeutic idea by analyzing T cell immune checkpoint in tumor microenvironment by algorithm: A bibliometric analysis. Human vaccines & immunotherapeutics 19 (3) (2023)
Qing Wang, Peixi Dai, Mengmeng Jia, Mingyue Jiang, Juan Li, Weizhong Yang, Lu-Zhao Feng
Construction of an indicator framework for vaccine inclusion in public health programs: A Delphi-entropy method study. Human vaccines & immunotherapeutics 19 (3) (2023)
Peng Chen, Zheng Chen, Yi Xiao, Xiang Chen, Ji Li, Yan Tang, Minxue Shen
Characteristics and economic burden of hospitalized patients with herpes zoster in China, before vaccination. Human vaccines & immunotherapeutics 19 (3) (2023)
Zongwei Lv, Junhui Hou, Yuan Wang, Xia Wang, Yibing Wang, Kefeng Wang
Knowledge-map analysis of bladder cancer immunotherapy. Human vaccines & immunotherapeutics 19 (3) (2023)
Jubao Niu, Wenkai Jiang, Dongao Fan, Xin Li, Wence Zhou, Hui Zhang
Research trends on immunotherapy for pancreatic cancer: A bibliometric analysis. Human vaccines & immunotherapeutics 19 (3) (2023)
Tae Un Yang, Juan C Vargas-Zambrano, Hang A Park, Chae Won Jung, Dongwook Kim, Youngmee Jee
Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus. Human vaccines & immunotherapeutics 19 (3) (2023)
Zufishan Alam, Salma Mohamed, Javaid Nauman, Rami H Al-Rifai, Luai Awad Ahmed, Iffat ElBarazi
Response to Letter to the Editor by Amnuay Kleebayoon, Viroj Wiwanitkit titled: Hesitancy toward vaccination against COVID-19. Human vaccines & immunotherapeutics 19 (3) (2023)
Xiaolan Yong, Jun Liu, Ying Zeng, Jing Nie, Xuelian Cui, Tao Wang, Yilin Wang, Yiyong Chen, Wei Kang, Zhonghua Yang, Yan Liu
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine. Human vaccines & immunotherapeutics 19 (3) (2023)
Stefano Bibbo, Serena Porcari, Livio Enrico Del Vecchio, Andrea Severino, Benjamin H Mullish, Gianluca Ianiro, Antonio Gasbarrini, Giovanni Cammarota
Gut microbiota and immunotherapy of renal cell carcinoma. Human vaccines & immunotherapeutics 19 (3) (2023)
Racquel E Kohler, Rachel B Wagner, Katherine Careaga, Rula Btoush, Kathryn Greene, Leslie Kantor
Mothers' perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds. Human vaccines & immunotherapeutics 19 (3) (2023)
Ronald Ellis, Adam Weiss
HV&I reviewer highlight. Human vaccines & immunotherapeutics 19 (3) (2023)
Ronald Ellis, Adam Weiss
Human vaccines and immunotherapeutics: News September 2023. Human vaccines & immunotherapeutics 19 (3) (2023)
Henri-Corto Stoeklé, Sakina Sekkate, Jean-Marc Ayoubi, Jaafar Bennouna, Philippe Beuzeboc, Christian Hervé
Vaccination against HPV: Easier said than done? Human vaccines & immunotherapeutics 19 (3) (2023)
Greg J. Marchand, Ahmed Masoud
Response to Dr. Somovilla del Saz's letter to the editor regarding "Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies". Human vaccines & immunotherapeutics 19 (3) (2023)